All Articles
Today, more people, including patients diagnosed with chronic lymphocytic leukemia, are living longer with cancer thanks to advancements in cancer treatments. Improvements in the chance for long-term cancer remission are clearly important but living with cancer can also bring a new set of challenges. Read More ›
People with cancer, including people who have been diagnosed with chronic lymphocytic leukemia, do not need to face it alone. Valuable online and local resources are available for patients with cancer and their loved ones. Read More ›
For many patients with chronic lymphocytic leukemia (CLL), treatment is personalized. This means that oncologists tailor their medication choices based on the patient’s unique CLL characteristics and medical status. Read More ›
Targeted therapies are effective in controlling chronic lymphocytic leukemia (CLL). New research is now looking into the impact that these agents can have on autoimmune conditions. Read More ›
A new type of immunotherapy, allogeneic cord blood–derived CAR NK-cells, could be a future option for patients with chronic lymphocytic leukemia (CLL), based on results from an early-phase clinical trial showing high response rates among patients. Read More ›
Machines that use artificial intelligence—such as Siri and Alexa—have become part of our everyday lives. Could this technology help in the fight against breast cancer? See how human doctors stacked up against machines in one study. Read More ›
By Dana Taylor
Calquence, a new-generation targeted therapy recently approved for the treatment of CLL, has shown good results in a 3-drug combination therapy. Read More ›
Dr. Joan Schiller, like many cancer care advocates, is working to change the negative attitudes and misconceptions about lung cancer, which is often seen as being caused by the patient, but in reality affects many people who never have smoked. Read More ›
Knowing the stage of lung cancer helps oncologists to plan the best treatment plan for each patient. This first article in the series explains how the most common type of lung cancer is staged. Read More ›
By Mia Brister
When 24-year-old Mia Brister was diagnosed with Hodgkin lymphoma, it was as if her whole world had shattered. She had to learn to be kind with herself to put her life together again. Read More ›